Ritemvia (previously Vypanra)
- Licence status
- Withdrawn: 21/06/2021
- Active substances
- Rituximab
- Dosage Form
- Concentrate for solution for infusion
- Licence number
- EU/1/17/1207/001
- Licence holder
- Celltrion Healthcare Hungary Kft.
Licence information
- ATC code
- L01XC Monoclonal antibodies, L01XC02 rituximab
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 13/07/2017